PROPANC BIOPHARMA, INC. Debt Instrument, Interest Rate During Period
PROPANC BIOPHARMA, INC. (PPCB) reported Debt Instrument, Interest Rate During Period of 12.00% for the 0-month period ending 2014-08-06, per its 10-Q filed 2014-11-19.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentInterestRateDuringPeriod · last filed 2014-11-19
- 2014-08-06: Debt Instrument, Interest Rate During Period 0 month 12.00%.
| Period end | Debt Instrument, Interest Rate During Period 0 month |
|---|---|
| 2014-08-06 | 12.00% 10-Q · filed 2014-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |